WallStSmart
TMDX

TransMedics Group Inc

NASDAQ: TMDX · HEALTHCARE · MEDICAL DEVICES

$98.57
-2.66% today

Updated 2026-04-29

Market cap
$3.41B
P/E ratio
20.24
P/S ratio
5.62x
EPS (TTM)
$4.87
Dividend yield
52W range
$89 – $156
Volume
1.0M

TransMedics Group Inc (TMDX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062016201720182019202020212022202320242025
Revenue$6.21M$7.68M$13.02M$23.60M$25.64M$30.26M$93.46M$241.62M$441.54M$605.49M
Revenue growth (YoY)+23.8%+69.4%+81.3%+8.6%+18.0%+208.8%+158.5%+82.7%+37.1%
Cost of revenue$5.44M$5.55M$7.28M$9.74M$9.00M$9.10M$28.19M$87.53M$179.46M$242.69M
Gross profit$766000.00$2.14M$5.73M$13.86M$16.64M$21.16M$65.27M$154.09M$262.08M$362.81M
Gross margin12.3%27.8%44.1%58.7%64.9%69.9%69.8%63.8%59.4%59.9%
R&D$13.64M$15.64M$14.96M$13.66M$19.87M$18.83M$22.30M$26.81M$63.27M$55.97M$69.06M
SG&A$4.60M$8.12M$7.61M$12.31M$21.52M$24.19M$38.28M$51.69M$119.55M$168.62M$185.17M
Operating income$-18.24M$-22.99M$-20.43M$-20.24M$-29.60M$-26.38M$-39.43M$-31.44M$-28.73M$37.50M$108.58M
Operating margin-370.2%-265.8%-155.5%-125.4%-102.9%-130.3%-33.6%-11.9%8.5%17.9%
EBITDA$-22.66M$-19.09M$-20.23M$-27.93M$-23.15M$-38.49M$-28.96M$-7.70M$69.95M$148.49M
EBITDA margin-365.0%-248.4%-155.4%-118.3%-90.3%-127.2%-31.0%-3.2%15.8%24.5%
EBIT$-18.24M$-23.09M$-19.72M$-21.00M$-29.15M$-24.73M$-40.30M$-32.44M$-15.88M$50.19M$121.30M
Interest expense$0.00$979000.00$1.07M$2.42M$4.35M$3.98M$3.87M$3.73M$10.79M$14.41M$13.78M
Income tax$984000.00$32000.00$41000.00$40000.00$32000.00$36000.00$66000.00$-1.64M$316000.00
Effective tax rate0.0%-4.3%-0.2%-0.2%-0.1%-0.1%-0.1%-0.2%6.2%0.9%0.0%
Net income$-17.55M$-24.07M$-20.82M$-23.76M$-33.55M$-28.75M$-44.22M$-36.23M$-25.03M$35.46M$190.29M
Net income growth (YoY)-37.1%+13.5%-14.1%-41.2%+14.3%-53.8%+18.1%+30.9%+241.7%+436.6%
Profit margin-387.6%-271.0%-182.5%-142.1%-112.1%-146.1%-38.8%-10.4%8.0%31.4%